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Summary 18 
Protection from infectious disease relies on two distinct mechanisms. “Antimicrobial resistance” 19 
directly inhibits pathogen growth, whereas “infection tolerance” controls tissue damage. A single 20 
immune-mediator can differentially contribute to these mechanisms in distinct contexts, 21 
confounding our understanding of protection to different pathogens. For example, the NADPH-22 
dependent phagocyte oxidase complex (Phox) produces anti-microbial superoxides and 23 
protects from tuberculosis in humans. However, Phox-deficient mice do not display the 24 
expected defect in resistance to M. tuberculosis leaving the role of this complex unclear. We re-25 
examined the mechanisms by which Phox contributes to protection from TB and found that mice 26 
lacking the Cybb subunit of Phox suffered from a specific defect in tolerance, which was due to 27 
unregulated Caspase1 activation, IL-1β production, and neutrophil influx into the lung. These 28 
studies demonstrate that Phox-derived superoxide protect against TB by promoting tolerance to 29 
persistent infection, and highlight a central role for Caspase1 in regulating TB disease 30 
progression. 31 
  32 
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Introduction 33 
Protective immunity to infectious disease involves functionally overlapping responses 34 
that can be divided into two fundamentally different categories (Medzhitov et al., 2012; 35 
Schneider and Ayres, 2008). Infection “resistance” refers to functions that directly target the 36 
infecting pathogen to prevent its growth and dissemination. Resistance pathways act by a 37 
variety mechanisms including disrupting the bacterial niche, serving as metabolic poisons, and 38 
sequestering critical nutrients (Hood and Skaar, 2012; Olive and Sassetti, 2016; Pilla-Moffett et 39 
al., 2016). In addition, the extent of disease is also influenced by “tolerance” mechanisms that 40 
enhance host survival but do not directly impact pathogen growth (Ayres and Schneider, 2008; 41 
Jamieson et al., 2013; Weis et al., 2017). Tolerance pathways control a broad range of functions 42 
that protect the infected tissues from both the direct cytotoxic properties of the pathogen and 43 
inflammation-mediated immunopathology. While it is well appreciated that both resistance and 44 
tolerance mechanisms are required to limit disease, the relative importance of these pathways 45 
vary for different infections (Medzhitov et al., 2012). Furthermore, since individual immune 46 
effectors can promote both tolerance and resistance, the specific role for each mediator can 47 
change in different contexts (Jeney et al., 2014; Medzhitov et al., 2012; Meunier et al., 2017; 48 
Mishra et al., 2017).  In the context of chronic infections, where resistance mechanisms are 49 
insufficient and the pathogen persists in the tissue, tolerance is likely to play a particularly 50 
important role (Meunier et al., 2017).  51 
Like many other chronic infections, the outcome of an encounter with Mycobacterium 52 
tuberculosis (Mtb) varies dramatically between individuals (Cadena et al., 2017). Only 5-10% of 53 
those that are infected with this pathogen progress to active tuberculosis (TB), and disease 54 
progression is influenced by a wide-variety of genetic and environmental factors that could 55 
modulate either tolerance or resistance (Chen et al., 2014; Lopez et al., 2003; Tobin et al., 56 
2012). For example, observations from humans and mice indicate that several specific changes 57 
in T cell function may contribute to a failure of resistance and disease progression due to loss of 58 
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antimicrobial resistance (Jayaraman et al., 2016; Larson et al., 2013; Redford et al., 2011). In 59 
addition, studies in animal models indicate that a failure of host tolerance, which is necessary to 60 
preserve lung function or granuloma structure, influences the extent of disease (Desvignes et 61 
al., 2015; Pasipanodya et al., 2010). While these studies suggest that variation in overall 62 
tolerance may be an important determinant TB risk, the specific tolerance mechanisms that 63 
influence disease progression in natural populations remain ill defined.  64 
During many bacterial infections the production of reactive oxygen species (ROS) by the 65 
NADPH phagocyte oxidase (Phox) is essential to protect the host from disease (Segal, 2005). 66 
Phox is a multi-protein complex, including the subunits Cybb (gp91) and Ncf1 (p47) that 67 
assemble in activated immune cells to produce superoxide radicals by transferring electrons 68 
from NADPH to molecular oxygen (Panday et al., 2015). Humans with deleterious mutations in 69 
the Phox complex develop a clinical syndrome known as chronic granulomatous disease 70 
(CGD). Leukocytes from patients with CGD are unable to kill a number of bacterial pathogens, 71 
such as Staphylococcus aureus and Serratia marcescens, and this defect is associated with the 72 
susceptibility to infection with these organisms (Johnston and Baehner, 1970). Because ROS 73 
contributes to the microbicidal activity of phagocytes, previous studies in Mtb-infected mice 74 
focused on the role of Phox in antimicrobial resistance. However, mice deficient in Phox are 75 
able to restrict Mtb growth to levels comparable to wild type animals during the initial stages of 76 
infection (Deffert et al., 2014a; Jung et al., 2002); (Cooper et al., 2000; Jung et al., 2002). The 77 
lack of an obvious antimicrobial role for Phox has been attributed to the expression of 78 
mycobacterial defenses, such as the catalase/peroxidase, KatG, which detoxifies ROS directly, 79 
or CpsA which prevents Phox localization to the Mtb containing vacuole (Colangeli et al., 2009; 80 
Koster et al., 2017; Nambi et al., 2015; Ng et al., 2004). These findings have led to the 81 
conclusion that ROS produced by Phox are not required for protection to Mtb (Nathan and 82 
Shiloh, 2000). In contrast, mutations in the Cybb gene are strongly associated with susceptibility 83 
to mycobacterial disease, including tuberculosis (Bustamante et al., 2011; Deffert et al., 2014a; 84 
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Khan et al., 2016; Lee et al., 2008). Mutations that specifically reduce Cybb activity in 85 
macrophages produce a similar clinical presentation, highlighting the importance of the 86 
macrophage-derived ROS in protection from pathogenic mycobacteria (Bustamante et al., 87 
2011). The apparently conflicting data from mice and humans regarding the importance of Phox 88 
during Mtb infection suggest two possibilities. Either Phox is differentially required to protect 89 
against Mtb in mice and humans or the ROS produced by Phox is necessary to control immune 90 
mechanisms that do not directly modulate bacterial replication.  91 
Here we re-examined the role of Phox in the context of Mtb infection. Consistent with 92 
previous reports we found that loss of the Phox subunit Cybb does not alter the growth or 93 
survival of Mtb during infection. Instead, Cybb-/- animals suffered from a hyper-inflammatory 94 
disease caused by increased activation of the NLRP3-dependent Caspase-1 inflammasome 95 
and IL-1-dependent neutrophil accumulation in the lung. Thus, the protective effect of Phox can 96 
be attributed to increased tolerance to Mtb infection instead of a direct antimicrobial effect. 97 
These studies provide a mechanism to explain the association between Phox expression and 98 
TB disease in natural populations, and implicate Caspase-1 as an important regulator of 99 
infection tolerance. 100 
 101 
Results 102 
Cybb-/- mice are susceptible to TB disease, but maintain control of bacterial replication. 103 
In order to re-examine the role of Phox in mediating protection against Mtb, we compared 104 
disease progression and the immune responses in wild type and Cybb-/- C57BL/6 mice after 105 
infection via aerosol with 50-100 bacteria. We found no significant difference in the survival or 106 
bacterial levels in the lung between groups of mice up to 3 months following infection, 107 
confirming that Cybb is not required for surviving the early stages of Mtb infection (Figure 1A). 108 
However, after 100 days of infection, Cybb-/- infected mice lost an average of 10% of their body 109 
weight while wild type animals gained weight (Figure 1B). Histopathological inspection of the 110 
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lungs also indicated a difference in disease between these groups, with Cybb-/- lungs containing 111 
larger and less organized lesions than wild type (Figure 1C). These data suggested that wild 112 
type and Cybb-/- animals might tolerate Mtb infection differently even while harboring identical 113 
levels of bacteria.  114 
In order to dissect the mechanisms controlling tolerance to Mtb disease in Cybb-/- mice, 115 
we profiled the infected lungs of animals during infection by flow cytometry. We found no 116 
significant differences in the numbers of dendritic cells, macrophages, B cells, as well as total T 117 
cells between wild type and Cybb-/- mice (Figure S1). In contrast, we observed an early and 118 
sustained increase of Ly6G+ CD11b+ neutrophils in the infected lungs of Cybb-/- mice (Figure 1D 119 
and 1E). A 3-5-fold increase in the total number neutrophils was observed as early as 4 weeks 120 
following infection and was maintained throughout the 12-week study.  121 
The cytokine IL-1β promotes neutrophil-mediated disease during Mtb infection of other 122 
susceptible mouse strains (Mishra et al., 2017; Mishra et al., 2013). Similarly, when we assayed 123 
cytokine levels in lung homogenates, we noted a dramatic and specific increase in IL-1β 124 
concentration in Cybb-/- animals compared to wild type at all time points. In contrast, no 125 
significant differences were noted for IFNγ or TNFα at any time point between groups. Thus, 126 
while the adaptive immune response to Mtb appeared to be intact, Cybb-/- animals produced 127 
excess IL-1β and the concentration of this cytokine correlated with neutrophil infiltration into the 128 
lung.  129 
Previous studies have shown that following low dose aerosol infection mice deficient in 130 
Phox (both Cybb-/- or p47-/-) survive for at least 60 days (Cooper et al., 2000; Jung et al., 2002). 131 
However, longer infection is likely necessary to determine whether the enhanced disease we 132 
noted in Cybb-/- mice would result in a survival defect. These long-term survival experiments 133 
following low dose aerosol proved difficult, since uninfected Cybb-/- mice develop arthritis as 134 
they age (Lee et al., 2011). To avoid this confounder, we quantified the survival of mice in a 135 
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shorter-term study using a high dose aerosol infection. When mice were infected with ~5000 136 
CFU per animal, Cybb-/- mice succumbed to disease significantly more rapidly than wild type 137 
animals. Cybb-/- mice had a median survival time of 88 days while only two out of fifteen wild 138 
type mice succumbed during the 120 day study (Figure 1K). In order to distinguish survival 139 
effects not related to Mtb infection, a cohort of uninfected age-matched Cybb-/- mice were 140 
maintained for the duration of the experiment. None of these animals required euthanasia over 141 
the 120 days and no animals included in this experiment developed arthritis.  142 
During this high-dose study, we also examined a cohort of mice 50 days following 143 
infection and found identical levels of bacteria in the lungs and spleen between wild type and 144 
Cybb-/- groups (Figure1G). Consistent with our earlier findings, Cybb-/- mice showed a significant 145 
increase in neutrophils and IL-1β in the lung (Figure 1H-J). We also found minimal levels of IL-146 
1β and neutrophils in uninfected Cybb-/- lungs indicating that these phenotypes are dependent 147 
on Mtb infection. Therefore, the loss of Cybb leads to more severe Mtb disease that is 148 
associated with increased IL-1β levels and neutrophil recruitment, even though the number of 149 
viable Mtb in the lung did not appear to be affected. 150 
 151 
Cybb controls tolerance to Mtb infection. 152 
Our initial results suggested that Cybb protects mice by promoting tolerance to Mtb infection 153 
rather than directly controlling bacterial replication. However, while viable bacterial numbers 154 
were similar in wild type and Cybb-/- mice, we could not rule out that the course of disease was 155 
altered by subtle changes in the dynamics of bacterial growth and death. To more rigorously 156 
address this question, we employed two additional animal models that allowed us to 157 
differentiate tolerance and direct antimicrobial resistance in vivo.  158 
 To more formally exclude the possibility that Cybb alters the intracellular growth of Mtb 159 
during infection, we used a previously optimized mixed bone marrow chimera approach (Mishra 160 
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et al., 2017). These experiments normalize potential inflammatory differences between wild type 161 
and Cybb-/- mice allowing us to specifically quantify differences in bacterial control (Figure 2A). 162 
Irradiated wild type mice were reconstituted with a 1:1 mixture of CD45.1+ wild type and 163 
CD45.2+ Cybb-/- or wild type cells. Five weeks following infection, both CD45.1+ and CD45.2+ 164 
cells were sorted from the lungs and the levels of Mtb in each genotype was determined by 165 
plating and the purity of populations was determined by flow cytometry (Figure 2B and 2C and 166 
Figure S2). We found that the relative abundance of wild type and Cybb-/- cells was similarly 167 
maintained throughout infection in both the myeloid and lymphoid compartments, indicating that 168 
Cybb does not alter cellular recruitment or survival in a cell-autonomous manner. When Mtb 169 
was enumerated in sorted cells, we found identical levels of H37Rv in wild type CD45.1+ and 170 
Cybb-/- CD45.2+ populations from the same mouse, similar to the results from mice where both 171 
populations were reconstituted with congenically mismatched wild type cells. In contrast, when 172 
chimeric mice were infected with a ROS-sensitive ∆katG mutant of Mtb, we found higher levels 173 
of bacteria in Cybb-/- cells compared to wild type cells from the same mouse. These data show 174 
that the assay is able to detect the cell-autonomous antimicrobial activity of ROS against a 175 
KatG-deficient Mtb strain, but Cybb-dependent ROS did not restrict the intracellular replication 176 
of wild type Mtb.  177 
To specifically determine if the loss of Cybb decreased tolerance to a given burden of 178 
bacteria, wild type and Cybb-/- mice were infected with a streptomycin auxotrophic strain of Mtb 179 
that allows exogenous control of bacterial replication during infection. Streptomycin is provided 180 
for the first two weeks of infection, allowing the pathogen to reach the burden observed in a wild 181 
type Mtb infection. Upon streptomycin withdrawal, the pathogen is unable to replicate but 182 
remains viable and able to drive inflammatory responses (Figure 2D) (Honore et al., 1995; 183 
Mishra et al., 2017; Mishra et al., 2013). Five weeks after infection, Cybb-/- mice lost more 184 
weight than wild type animals while harboring identical levels of non-replicating bacteria (Figure 185 
2E and 2F). Lungs from Cybb-/- mice contained significantly more neutrophils and higher levels 186 
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of IL-1β compared to wild type animals (Figure 2G-2I). Thus, even when the need for 187 
antimicrobial resistance is obviated by artificially inhibiting bacterial replication, Cybb-/- animals 188 
continued to exhibit a hyper-inflammatory disease.  189 
The granulocytic inflammation observed in Cybb-/- mice was reminiscent of several other 190 
susceptible mouse strains. However, the neutrophil recruitment in other models is generally 191 
associated with a concomitant increase in bacterial growth (Kimmey et al., 2015; Kramnik et al., 192 
2000; Nandi and Behar, 2011) and a transition of the intracellular Mtb burden from 193 
macrophages to granulocytes (Mishra et al., 2017). We hypothesized that Cybb-/- mice may be 194 
able to retain control of Mtb replication because the bacteria remain in macrophages. To test 195 
this hypothesis, we used a YFP-expressing Mtb strain to compare the distribution of cells 196 
harboring bacteria in wild type and Cybb-/- mice with Nos2-/- animals in which Mtb replicates to 197 
high numbers in association with infiltrating granulocytes (Mishra et al., 2017). Four weeks 198 
following infection we found that lungs from both Cybb-/- and Nos2-/- mice contain higher levels 199 
of IL-1β and neutrophils than wild type animals, although the loss of Nos2-/- produced a much 200 
more severe phenotype than Cybb-/-. (Figure 2J-2L and Figure S2). However, the cells 201 
harboring Mtb in these two susceptible mouse strains differed. In wild type and Cybb-/- mice, 202 
YFP-Mtb was evenly distributed between CD11b+/Ly6G+ neutrophils and the CD11b+/Ly6G- 203 
population that consists of macrophages and dendritic cells (Wolf et al., 2007). This proportion 204 
was dramatically altered in Nos2-/- mice, where close to 90% of bacteria were found in the 205 
neutrophil compartment. (Figure 2M and 2N). Thus, unlike other susceptible mouse models, the 206 
loss of Cybb does not alter bacterial replication or the distribution of Mtb in different myeloid 207 
subsets. Instead, this gene plays a specific role in controlling IL1β production, neutrophil 208 
recruitment to the infected lung, and disease progression. As a result, we conclude that Cybb 209 
specifically promotes tolerance to Mtb infection.   210 
 211 
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Enhanced IL-1β production by Cybb-/- macrophages and dendritic cells is due to 212 
deregulated Caspase-1 inflammasome activation 213 
 To investigate the mechanism underlying increased IL-1β production in Cybb-/- mice, we 214 
quantified the release of mature cytokine from bone-marrow derived macrophages (BMDMs) 215 
and bone-marrow derived dendritic cells (BMDCs). Compared to wild type, we found that Cybb-/- 216 
BMDMs and BMDCs produced 4-5 fold more IL-1β after 24 hours of Mtb infection (Figure 3A 217 
and 3D). Under these conditions, wild type and Cybb-/- cells remained equally viable and 218 
produced equivalent amounts of TNF (Figure 3B-F), suggesting that the effect of Cybb on IL-1β 219 
production was specific to this cytokine.  220 
 The production of mature IL-1β requires two distinct signals (von Moltke et al., 2013). 221 
The first signal induces the expression of Il1b mRNA and subsequent production of pro-IL-1β, 222 
and a second signal activates Caspase1, which is necessary for the processing and secretion of 223 
mature IL-1β. To understand what step of IL1β production was altered in Cybb-/- cells, we 224 
quantified these two signals. The expression of Il1b mRNA in uninfected and infected BMDMs 225 
was unchanged between wild type and Cybb-/- BMDMs (Figure 3G). In contrast, under the same 226 
conditions, the processing of Caspase1 to its active form was increased in infected Cybb-/- 227 
BMDMs compared to wild type cells (Figure 3H).  228 
These observations suggested that caspase-1 activity is increased in Cybb-/- cells, which 229 
could allow mature IL-1β secretion in the absence of an inflammasome activator. To test this 230 
hypothesis, we stimulated cells with the TLR2 agonist, PAM3CSK4, to induce pro- IL-1β 231 
production. PAM3CSK4 stimulation induced Il1b mRNA to similar levels between wild type and 232 
Cybb-/- BMDMs, albeit over 100 times higher than infection with Mtb (Figure 3I). In wild type 233 
cells, this induction of Il1b expression produced little mature IL-1β secretion, consistent with the 234 
need for subsequent inflammasome activation. In contrast, induction of Il1b expression led to 235 
robust secretion of mature IL-1β from Cybb-/- BMDM, consistent with unregulated inflammasome 236 
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activity in these cells (Figure 3J). Together these data show that loss of Cybb leads to hyper-237 
activation of Caspase1 and increased release of IL-1β during Mtb infection of both BMDMs and 238 
BMDCs.  239 
   240 
Loss of tolerance is reversed in Cybb-/- macrophages and mice by blocking the 241 
production or activity of IL-1β 242 
The NLRP3 inflammasome consists of NLRP3, ASC, and Caspase 1. While this 243 
complex is generally responsible for IL-1β processing in Mtb infected macrophages (Coll et al., 244 
2015; Dorhoi et al., 2012), it remained unclear whether the enhanced IL-1β secretion from Cybb-245 
/-
 cells also relied on these components. To identify the responsible complex, we blocked the 246 
activation of the NLRP3 inflammasome in several distinct ways. The NLRP3 inflammasome is 247 
specifically inhibited by IFNγ stimulation, via the nitric oxide-dependent nitrosylation of the 248 
NLRP3 protein (Mishra et al., 2013). Pretreatment of wild type and Cybb-/- BMDMs with varying 249 
concentrations of IFNγ, inhibited the secretion of IL-1β from both wild type and Cybb-/- BMDMs 250 
compared to untreated cells. While this result indicated an important role for NLRP3, IFNγ 251 
pretreatment did not completely suppress IL-1β secretion and there remained significant 252 
differences in the IL-1β release between Cybb-/- and wild type cells at all concentrations of the 253 
cytokine. 254 
To more directly assess the role of NLRP3 and Caspase-1 in IL-1β production by Cybb-/- 255 
cells, we employed specific small molecule inhibitors. Treatment of Mtb-infected BMDMs with 256 
either the NLRP3 inhibitor, MCC950 (Coll et al., 2015), or the Caspase-1 inhibitor, VX-765 257 
(Stack et al., 2005) caused a dramatic reduction in IL-1β in both wild type and Cybb-/- BMDMs 258 
compared to untreated cells (Figure 4B and 4C).  This ten-fold decrease in IL-1β secretion could 259 
not be attributed to inhibition of pro-IL-1β levels, as none of these inhibitors affected Il1b mRNA 260 
by more than two-fold. Similarly, the spontaneous IL-1β secretion observed upon PAM3CSK4 261 
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stimulation was also inhibited by MCC950 and IFNγ, (Figure 4E). In each case inflammasome 262 
inhibition reduced IL-1β secretion to the same level in both wild type and Cybb-/- cells, indicating 263 
that the NLRP3 inflammasome was responsible for the enhanced production of this cytokine in 264 
Cybb-/- BMDM.  265 
Based on these studies, we hypothesized that the tolerance defect observed in the intact 266 
mouse was due to inflammasome-dependent IL-1 signaling. IL-1β serves a complex role during 267 
infection (Mayer-Barber et al., 2010; Nunes-Alves et al., 2014). Some production of this cytokine 268 
is important for the antimicrobial immunity, but persistent production can lead to pathology. In 269 
order to focus on the role of over-production of IL-1β on tolerance, we inhibited IL-1 signaling in 270 
mice infected with non-replicating auxotrophic Mtb to normalize the bacterial burden. Two 271 
weeks after infection, wild type and Cybb-/- mice were treated with either an isotype control 272 
antibody or an anti-IL1R antibody to block the effect of increased IL-1β production. As expected, 273 
Mtb levels were similar in all mice, but more neutrophils accumulated in the lungs Cybb-/- 274 
animals (Figure 4F-H). While anti-IL-1R treatment had no effect in wild type animals, inhibition 275 
of IL-1 signaling reduced neutrophil infiltration in Cybb-/- mice to the level observed in wild type 276 
animals. Taken together, our data show that Cybb-/- contributes to protective immunity to Mtb 277 
not by controlling bacterial replication, but instead by preventing an IL1 dependent inflammatory 278 




The role of the Phox complex in protection from TB has presented a paradox (Deffert et al., 283 
2014a). Based on the well-described antimicrobial properties of Phox-derived ROS, previous 284 
studies have focused on examining the function of Phox components in controlling Mtb 285 
replication in mice (Cooper et al., 2000; Deffert et al., 2014b; Jung et al., 2002). The minimal 286 
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effects observed in these assays suggested that Phox may not play a protective role in TB. This 287 
conclusion contrasts with several studies indicating that human CGD patients show increased 288 
susceptibility to TB disease (Bustamante et al., 2011; Deffert et al., 2014a; Khan et al., 2016). 289 
Our dissection of disease progression in Cybb-deficient mice harmonizes these conflicting 290 
observations. While we verify that Phox plays no discernable role in antimicrobial resistance to 291 
Mtb, we uncovered a previously unknown role for this complex in promoting tolerance to Mtb 292 
infection and inhibiting TB disease progression.  293 
While we were able to clearly delineate the role of Phox during Mtb infection, the role(s) 294 
played by this complex in any given infection is likely to vary. Phox-deficient mice are unable to 295 
control the growth of several bacterial pathogens that are known to cause serious infections in 296 
CGD patients, including non-tuberculous mycobacteria (Deffert et al., 2014b; Dinauer et al., 297 
1997; Fujita et al., 2010; Jackson et al., 1995). In the context of these infections, the 298 
antimicrobial functions of Phox may predominate. In contrast, for pathogens such as Mtb that 299 
are resistant to ROS-mediated toxicity and persist in the tissue to promote continual 300 
inflammatory damage, the tolerance-promoting activity of Phox appears to play a dominant role.  301 
During Mtb infection, we found that the ROS produced by Phox are critical to control the 302 
activation of the NLRP3 inflammasome. In contrast, mitochondrial ROS are well known to 303 
activate inflammatory cascades (Weinberg et al., 2015), suggesting that the context by which 304 
ROS are produced influences the inflammatory outcome of activated cells. Despite this 305 
complexity, Phox-deficient mice and CGD patients suffer from hyper-inflammatory diseases 306 
including arthritis, colitis, and prolonged inflammatory reactions to microbial products, indicating 307 
that the dominant immunoregulatory role for Phox-derived ROS is anti-inflammatory 308 
(Morgenstern et al., 1997; Schappi et al., 2008; Segal et al., 2010). Several non-mutually 309 
exclusive mechanisms could explain this anti-inflammatory effect. For example, the loss of Phox 310 
derived ROS has been proposed to promote the production of inflammatory mediators by 311 
inhibiting autophagy (de Luca et al., 2014). Another mechanism was described in superoxide 312 
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dismutase1 (Sod1) deficient cells, where the accumulation of ROS inhibits Caspase1 activation 313 
through glutathionation of reactive cysteines (Meissner et al., 2008). This latter mechanism is 314 
reminiscent of the process by which nitric oxide (NO), inhibits inflammasome activation via S-315 
nitrosylation of NLRP3 (Mishra et al., 2013). The intersection of these two important anti-316 
inflammatory pathways at the NLRP3 inflammasome indicates that this complex may be a 317 
critical point of integration where inflammatory cascades are controlled during chronic infections. 318 
Our findings are consistent with a growing body of literature suggesting that 319 
inflammasome-derived IL-1 promotes TB disease progression. For example, genetic 320 
polymorphisms that increase the expression of IL1β or the production of IL-1 dependent pro-321 
inflammatory lipid mediators are associated with TB disease progression (Mishra et al., 2017; 322 
Zhang et al., 2014). Similarly, transcriptional signatures of inflammasome activation have been 323 
observed in severe forms of TB disease, such as meningitis (Marais et al., 2017) and TB-324 
associated immune reconstitution syndrome (Tan et al., 2016). Together with our work, these 325 
findings imply an important role for infection tolerance in protection from TB disease, and 326 
implicate Caspase-1 as a critical point at which tolerance is regulated.  327 
 328 
Materials and Methods 329 
Mice 330 
C57BL/6J (Stock # 000664), Cybb-/- (B6.129S-Cybbtm1Din/J stock # 002365), Nos2-/- (B6.129P2-331 
Nos2tm1Lau/j, stock # 002609), B6.SJL-Ptprca Pepcb carrying the pan leukocyte marker CD45.1 332 
(stock # 002014) were purchased from the Jackson Laboratory. Mice were housed under 333 
specific pathogen-free conditions and in accordance with the University of Massachusetts 334 
Medical School, IACUC guidelines. All animals used for experiments were 6-12 weeks except 335 
mixed chimeras that were infected at 16 weeks following 8 weeks of reconstitution. 336 
 337 
Mouse Infection 338 
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Wild type M. tuberculosis strain H37Rv was used for all studies unless indicated. This strain was 339 
confirmed to be PDIM-positive. Prior to infection bacteria were cultured in 7H9 medium 340 
containing 10% oleic albumin dextrose catalase growth supplement (OADC) enrichment 341 
(Becton Dickinson) and 0.05% Tween 80. H37Rv expressing msfYFP has been previously 342 
described and the episomal plasmid was maintained with selection in Hygromycin B (50ug/ml) 343 
added to the media (Mishra et al., 2017). For low and high dose aerosol infections, bacteria 344 
were resuspended in phosphate-buffered saline containing tween 80 (PBS-T). Prior to infection 345 
bacteria were sonicated then delivered via the respiratory route using an aerosol generation 346 
device (Glas-Col). Infections of mice with the streptomycin auxotrophic strain of Mtb (18b) have 347 
been previously described. In short mice were infected via intra-tracheal infection and treated 348 
daily with 2mg of streptomycin daily for two weeks. For anti-IL1R treatment mice were injected 349 
with 200ug of anti-IL1R antibody or Isotype control (Bio-xcell) every other day starting at day 14. 350 
Both male and female mice were used throughout the study and no significant differences in 351 
phenotypes were observed between sexes.  352 
 353 
Immunohistochemistry 354 
Lungs from indicated mice were inflated with 10% buffered formalin and fixed for at least 24 355 
hours then embedded in paraffin. Five-Micrometer—thick sections were stained with 356 
haematoxylin and eosin (H&E). All staining was done by the Diabetes and Endocrinology 357 
Research Center Morphology Core at the University of Massachusetts Medical School.  358 
 359 
Flow Cytometry 360 
Lung tissue was harvested in DMEM containing FBS and placed in C-tubes (Miltenyi). 361 
Collagenase type IV/DNaseI was added and tissues were dissociated for 10 seconds on a 362 
GentleMACS system (Miltenyi). Tissues were incubated for 30 minutes at 37C with oscillations 363 
and then dissociated for an additional 30 seconds on a GentleMACS. Lung homogenates were 364 
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passaged through a 70-micron filter or saved for subsequent analysis. Cell suspensions were 365 
washed in DMEM, passed through a 40-micron filter and aliquoted into 96 well plates for flow 366 
cytometry staining. Non-specific antibody binding was first blocked using Fc-Block. Cells were 367 
then stained with anti-Ly-6G Pacific Blue, anti-CD4 Pacific Blue, anti-CD11b PE, anti-CD11c 368 
APC, anti-Ly-6C APC-Cy7, anti-CD45.2 PercP Cy5.5, anti-CD3 FITC, anti-CD8 APC-Cy7, anti-369 
B220 PE-Cy7 (Biolegend). Live cells were identified using fixable live dead aqua (Life 370 
Technologies). For infections with fluorescent H37Rv, lung tissue was prepared as above but no 371 
antibodies were used in the FITC channel. All of these experiments contained a non-fluorescent 372 
H37Rv infection control to identify infected cells. Cells were stained for 30 minutes at room 373 
temperature and fixed in 1% Paraformaldehyde for 60 minutes. All flow cytometry was run on a 374 
MACSQuant Analyzer 10 (Miltenyi) and was analyzed using FlowJo_V9 (Tree Star).  375 
 376 
Macrophage and Dendritic Cell Generation  377 
To generate bone marrow derived macrophages (BMDMs), marrow was isolated from femurs 378 
and tibia of age and sex matched mice as previously described. Cells were then incubated in 379 
DMEM (Sigma) containing 10% fetal bovine serum (FBS) and 20% L929 supernatant. Three 380 
days later media was exchanged with fresh media and seven days post-isolation cells were 381 
lifted with PBS-EDTA and seeded in DMEM containing 10% FBS for experiments.  382 
 To generate bone marrow derived dendritic cells (BMDCs) Marrow was isolated from 383 
femurs and tibia of age and sex matched mice. Cell were then incubated in iMDM media 384 
(GIBCO) containing 10% FBS, L-Glutamine, 2μM 2-mercaptoethanol and 10% B16-GM-CSF 385 
supernatant (Zanoni et al., 2016). BMDCs were then purified on day six using Miltenyi LS 386 
columns first using negative selection for F480 followed by CD11c positive selection. Cells were 387 
then plated and infected the following day.  388 
 389 
Macrophage and Dendritic Cell Infection 390 
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Mtb or Mycobacterium bovis-BCG were cultured in 7H9 medium containing 10% oleic albumin 391 
dextrose catalase growth supplement (OADC) enrichment (Becton Dickinson) and 0.05% 392 
Tween 80. Before infection cultures were washed in PBS-T, resuspended in DMEM containing 393 
10%FBS and passed through a 5-micron filter to ensure single cells. Multiplicity of infection 394 
(MOI) was determined by optical density (OD) with an OD of 1 being equivalent to 3x108 395 
bacteria per milliliter. Bacteria were added to macrophages for 4 hours then cells were washed 396 
with PBS and fresh media was added. At the indicated time points supernatants were harvested 397 
for cytokine analysis and the cells were processed for further analysis. Cell death was assessed 398 
using Cell-Titer-Glo luminescent cell viability assay (Promega) following manufacturer’s 399 
instructions. For inhibitor treatments cells were treated with the indicated concentrations of IFNγ 400 
(Peprotech), MCC950 (Adipogen) or VX-765 (Invivogen) or vehicle control overnight prior to 401 
infection and maintained in the media throughout the experiment. 402 
 403 
Mixed Bone Marrow Chimera generation and cell sorting 404 
Mixed bone marrow chimera experiments were done essentially as previously described. Wild-405 
type CD45.1
+
 mice were lethally irradiated with two doses of 600 rads. The following day, bone 406 
marrow from CD45.1
+
 wild-type mice and CD45.2
+
 knockout mice (wild-type or Cybb−/−) was 407 
isolated, red blood cells were lysed using Tris-buffered ammonium chloride (ACT), and the 408 




 cells were then 409 
mixed equally at a 1:1 ratio and 107 cells from this mixture were injected intravenously into 410 
lethally irradiated hosts that were placed on sulfatrim for three weeks. 8 weeks later mice were 411 
then infected by low-dose aerosol with M. tuberculosis H37Rv. Four weeks following infection, 412 
the lungs of chimera mice were processed for flow cytometry. An aliquot of this suspension was 413 
saved for flow cytometry analysis of the lung population and overall bacterial levels. The 414 
remaining cells were split equally and stained with either anti-CD45.1 APC or anti-CD45.2 PE. 415 
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Stained populations were then incubated with either anti-APC or anti-PE magnetic beads 416 
(Miltenyi) following the manufacturer’s instructions and sorted using LS-columns (Miltenyi). 417 
Purified cells were divided equally and then plated for M. tuberculosis on 7H10 agar or counted 418 
and stained for analysis of cellular purity. Cells from the input homogenate, flow through and the 419 
positive sort fractions were stained with for purity. Samples with >90% were used for 420 
subsequent analysis. At 21 days after plating, colonies were enumerated and the Mtb levels per 421 
sorted cells were determined.  422 
 423 
qRT-PCR 424 
Cells were lysed in Trizol-LS (Thermofisher), RNA was purified using Direct-zol RNA isolation 425 
kits (Zymogen) and quantified on nanodrop. RNA was diluted to 5ng/μl and 25 ng total RNA was 426 
used for each reaction. Ct values for each sample were determined in technical duplicates for β-427 
Actin and IL-1β using one-step RT-PCR Kit (Qiagen) on a Viia7 Real-time PCR system (Life 428 
Technologies). ΔΔct values were then determined for each sample.  429 
 430 
Immunoblotting and Cytokine quantification 431 
Murine cytokine concentrations in culture supernatants and cell-free lung homogenates were 432 
quantified using commercial enzyme-linked immunosorbent assay (ELISA) kits (R&D). All 433 
samples were normalized for total protein content. Caspase1 activation in macrophage lysates 434 
was determined by western blotting with Caspase1 antibody purchased from Adipogen.  435 
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Figure Legends  450 
 451 
Figure 1. Anti-inflammatory activity of Cybb protects mice from TB disease.  452 
A. Following low dose aerosol infection (Day 0 of ~50-100 colony forming units, cfu) total 453 
bacterial burden (expressed in cfu, mean +/- s.d.) was determined in the lungs of wild type or 454 
Cybb-/- mice at the indicated time points.  455 
B. Percentage weight loss (mean change +/- s.d) from Day 0 to Day 100 was determined for wild 456 
type and Cybb-/- mice.  457 
C. Immunohistochemical staining for Haemotoxylin and Eosin is shown for representative lung 458 
sections from wild type and Cybb-/- mice at 8 weeks post-infection at 20x magnification.  459 
D. Representative flow cytometry plot showing increased Ly6G+ CD11b+ neutrophil recruitment 460 
to the lungs of Cybb-/- mice 4 weeks following infection (gated on live/singlets/CD45+).  461 
E. Quantification of neutrophil recruitment to the lungs at the indicated time points following 462 
infection for wild type and Cybb-/- mice is shown as absolute number of Ly6G+ CD11b+ cells per 463 
lung (mean +/- s.d). * p-value <.05 by unpaired two-tailed t-test.  464 
F. Lung homogenates from wild type or Cybb-/- mice infected for the indicated time were probed 465 
for the cytokines IL-1β, IFNγ, and TNFα by ELISA (mean +/- s.d). Results shown in A-D are 466 
representative of 3 independent experiments with 3-5 mice per group. ** p-value <.01 by 467 
unpaired two-tailed t-test.  468 
G. Fifty days following high dose aerosol infection (Day 0 of 5000-7500 CFU) total bacterial 469 
burden (expressed in cfu, mean +/- s.d.) was determined in the lungs and spleen of wild type or 470 
Cybb-/- mice.  471 
H. Representative flow cytometry plot showing increased Ly6G+ CD11b+ neutrophil recruitment 472 
to the lungs of Cybb-/- mice 50 days following infection (gated on live/singlets/CD45+).  473 
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I. Quantification of the absolute number of neutrophils recruited to the lungs 50 days following 474 
high dose infection for wild type and Cybb-/- mice is shown (mean +/- s.d). ** p-value <.01 by one-475 
way ANOVA with tukey correction.  476 
J. Lung homogenates from wild type or Cybb-/- mice infected for 50 days following high dose 477 
aerosol were probed for IL-1β by ELISA (mean +/- s.d). ** p-value <.01 by unpaired two-tailed t-478 
test. Results shown in G-J are representative of 2 independent experiments with 5 mice per 479 
group. ** p-value <.01 by unpaired two-tailed t-test.  480 
K. Survival of infected wild type and Cybb-/- and uninfected Cybb-/- mice was determined 481 
following high dose infection. Data are representative of two independent experiments with 14-482 
15 mice per group. *** p-value <.001 Mantel-Cox text.  483 
 484 
Figure 2. The primary protective role of Cybb is anti-inflammatory.  485 
A. Schematic for the generation of mixed bone marrow chimeras. Mixed bone marrow chimeras 486 
were infected by low dose aerosol with either H37Rv or ΔKatG mutant. Five weeks following 487 
infection CFU levels were determined in purified haematopoietic cells of indicated genotypes.  488 
B. Shown are the normalized CFU per sorted cells in each population from each mouse. * p<.05 489 
by unpaired two-tailed t-test. 490 
C. The fold-increase of bacterial levels in CD45.2+ cells (experimental) compared to CD45.1+ 491 
cells (wild type control) (mean +/- s.d.). The results in B and C are representative of three 492 
independent experiments with 3-4 mice per group. 493 
D. Schematic for streptomycin-dependent auxotroph infection. Wild type and Cybb-/- mice were 494 
infected intratracheally with Mtb strain 18b and treated for two weeks daily with streptomycin. 495 
Mice were then removed from streptomycin for three weeks halting active growth of the 496 
bacteria. 497 
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E. Five weeks after infection the total levels of viable Mtb in the lungs was determined by CFU 498 
plating on streptomycin (mean +/- s.d.).  499 
F. Percentage weight loss (mean change +/- s.d) from Day 0 to Day 35 was determined for wild 500 
type and Cybb-/- mice.  501 
G. Representative flow cytometry plot showing increased Ly6G+ CD11b+ neutrophil recruitment 502 
to the lungs of Cybb-/- mice 5 weeks following infection (gated on live/singlets/CD45+).  503 
H. Quantification of neutrophil recruitment to the lungs at the indicated time points following 504 
infection for wild type and Cybb-/- mice is shown as absolute number of Ly6G+ CD11b+ cells per 505 
lung (mean +/- s.d). * p-value <.05 by unpaired two-tailed t-test. Data in D-G are representative 506 
of 4 independent experiments with 4-5 mice per group. 507 
I. Lung homogenates from wild type or Cybb-/- mice infected with 18b were probed for IL-1β by 508 
ELISA (mean +/- s.d). ** p-value <.01 by unpaired two-tailed t-test.  509 
J. Following low dose aerosol infection with sfYFP H37Rv (Day 0 of ~50-100 colony forming 510 
units, cfu) total bacterial burden (expressed in cfu, mean +/- s.d.) was determined in the lungs of 511 
wild type, Cybb-/- or Nos2-/- mice 4 weeks post-infection. ** p-value <.01 by one-way ANOVA 512 
with tukey correction.  513 
K. Shown are representative flow cytometry plots from each genotype of total Ly6G+ CD11b+ 514 
cells in the infected lungs.  515 
L. Quantification of total neutrophil recruitment to the lungs of the indicated genotypes four 516 
weeks following infection (mean +/- s.d.). ** p-value <.01 * p-value <.05 by one-way ANOVA with 517 
tukey correction.  518 
M. Shown are representative flow cytometry plots from each genotype of infected (YFP+ Ly6G+ 519 
CD11b+) cells in the lung. 520 
N. Enumeration of infected (YFP+) neutrophils (Ly6G+ CD11b+) or monocytes/macrophages 521 
(Ly6G- CD11b+) in the indicated genotypes. * p-value <.05 by unpaired two-tailed t-test.  522 
 523 
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Figure 3. Cybb controls Caspase1 activation in macrophages and dendritic cells during 524 
Mtb infection. Bone marrow-derived macrophages (BMDMs) or Bone marrow-derived dendritic 525 
cells (BMDCs) from wild type or Cybb-/- mice were left untreated or infected with Mtb for 4 hours 526 
then washed with fresh media. 18 hours later supernatants were harvested and the levels of A. 527 
and B. IL-1β and C. and D. TNFα were quantified in the supernatants by ELISA. Shown is the 528 
mean of 4 biological replicates normalized to a standard curve +/- s.d. *** p<.001 by unpaired 529 
two-tailed t-test.  530 
E. and F. Viability of remaining cells was determined by quantifying ATP via luminescence and 531 
compared to cells at 4 hours post-infection (mean % viability +/- s.d.). Data in A,C and E are 532 
representative of five independent experiments with at least 3 biological replicates per 533 
experiment. Data in B, D and F are representative of three independent experiments with 4 534 
biological replicates per experiment. 535 
G. Relative RNA expression of Il1b (compared to β-Actin) was determined from wild type and 536 
Cybb-/- BMDMs left untreated or infected for 24 hours with Mtb (mean +/- s.d.) by qRT-PCR. Data 537 
are representative of two independent experiments with 3-4 biological replicates per group.  538 
H. Immunoblot analysis was used to assess the activation of Caspase1 from Wild type and 539 
Cybb-/- BMDMs infected for 24 hours with Mtb. Total Caspase1 was used as a loading control. 540 
Data are representative of 3 independent experiments with at least 3 biological replicates 541 
analyzed per experiment. 542 
I. Relative RNA expression of Il1b (compared to Actb) was determined from wild type and Cybb-543 
/-
 BMDMs left untreated or treated with Pam3CSK4 for 24 hours (mean +/- s.d.) by qRT-PCR. 544 
Data are representative of two independent experiments with 3-4 biological replicates per group. 545 
J. Wild type and Cybb-/- BMDMs were left untreated or treated with PAM3CSK4 for 12 hours, 546 
supernatants were harvested and the levels of IL-1β were quantified by ELISA (mean +/- s.d.). ** 547 
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p<.01 by unpaired two-tailed t-test. Data are representative of three independent experiments 548 
with 4 biological replicates per experiment. 549 
 550 
Figure 4. Hyper-inflammation in Cybb-/- is reversed by inflammasome and IL1 inhibition.  551 
A. Wild type (Black Bars) and Cybb-/- (Grey Bars) BMDMs were left untreated or treated with 552 
with the indicated concentrations of IFNγ for 12 hours. Cells were then infected with Mtb for 4 553 
hours then washed with fresh media. 18 hours later supernatants were harvested and levels of 554 
IL-1β from each condition were quantified by ELISA (mean +/- s.d.). ** p-value <.01 * p-value 555 
<.05 by one-way ANOVA with tukey correction. Data are representative of three independent 556 
experiments with at least 3 biological replicates per experiment.  557 
B. Wild type and Cybb-/- BMDMs were left untreated or treated with the indicated concentrations 558 
of MCC950 for 2 hours. Cells were then infected with Mtb for 4 hours then washed with fresh 559 
media with inhibitor. 18 hours later supernatants were harvested and levels of IL-1β from each 560 
condition were quantified by ELISA (mean +/- s.d.). ** p-value <.01 by one-way ANOVA with 561 
tukey correction. Data are representative of three independent experiments with at least 3 562 
biological replicates per experiment.  563 
C. Wild type and Cybb-/- BMDMs were left untreated or treated with the indicated concentrations 564 
of VX-765 for 2 hours. Cells were then infected with Mtb for 4 hours then washed with fresh 565 
media with inhibitor. 18 hours later supernatants were harvested and levels of IL-1β from each 566 
condition were quantified by ELISA (mean +/- s.d.). ** p-value <.01 by one-way ANOVA with 567 
tukey correction. Data are representative of three independent experiments with at least 3 568 
biological replicates per experiment.  569 
D. Relative RNA expression of IL-1β (compared to b-Actin) was determined from wild type and 570 
Cybb-/- BMDMs left infected for 24 hours with Mtb in the presence or absence of the indicated 571 
inhibitors (mean +/- s.d.) by qRT-PCR.  572 
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E. Wild type and Cybb-/- BMDMs were left untreated or treated 25ng/ml IFNγ or 1μM MCC950 573 
overnight. The following day cells were treated with PAM3CSK4 for 12 hours, supernatants 574 
were harvested and the levels of IL-1β were quantified by ELISA (mean +/- s.d.). ** p<.01 by 575 
unpaired two-tailed t-test. Data are representative of two independent experiments with 4 576 
biological replicates per experiment. 577 
F. Wild type and Cybb-/- mice were infected intratracheally with Mtb strain 18b and treated for 578 
two weeks daily with streptomycin then were injected every other day for two weeks with 200ug 579 
of either isotype control antibody or anti-IL1R antibody. The total levels of viable Mtb in the 580 
lungs was determined by CFU plating on streptomycin (mean +/- s.d.).  581 
G. Representative flow cytometry plot showing Ly6G+ CD11b+ neutrophil recruitment to the 582 
lungs of Cybb-/- mice during control and IL1R blockade conditions (gated on 583 
live/singlets/CD45+).  584 
H. Quantification of neutrophil recruitment to the lungs at the indicated time points following 585 
infection for wild type and Cybb-/- mice during control and IL1R blockade conditions is shown as 586 
an absolute number of Ly6G+ CD11b+ cells per lung (mean +/- s.d). *** p-value <.001 ** p-value 587 
<.01 by one-way ANOVA with tukey correction. Data in F-G are representative of two 588 
independent experiments with 4-7 mice per group.  589 
 590 
Figure S1.  591 
A. Gating strategy used for all flow cytometry analysis. Shown is a representative gating 592 
approach for the analysis used throughout the paper. Cells were first gated on live/dead 593 
negative cells then forward by side scatter then singlets. We then gated on all CD45+ cells in 594 
and analyzed the subsequent populations using the indicated fluorescent markers. 595 
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B. Quantification of macrophages, B cells, Dendritic cells and T cells recruitment to the lungs at 596 
the 28 days following infection for wild type and Cybb-/- mice is shown as absolute number of 597 
cells per lung (mean +/- s.d).  598 
 599 
Figure S2.  600 
A. A representative sample of the purity of the cell populations depicted in “Figure 2b and c” 601 
were determined in the input and sorted fraction of MACS purification of the lung leukocytes 602 
from mixed-bone marrow chimeric mice.  603 
B. Lung homogenates from wild type, Cybb-/- or Nos2-/- mice infected with Mtb for 28 days were 604 
probed for the cytokines IL-1β by ELISA (mean +/- s.d). Results are representative of 3 605 
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